This report discusses the authors’ examination of the spatial distribution of drug-related deaths in the U.S., concluding that there is no longer one single drug crisis but rather different substance abuse trends that vary geographically and which require context-based responses.
There has been a rise in drug overdoses and death in recent years. The authors examine the spatial distribution of drug-related deaths in the U.S. by typing places by multiple problem substances and predicting the types with potential covariates. Units of analysis are counties in the 48 contiguous United States. Drug death rates by substance are drawn from confidential cause-of-death mortality files from the National Vital Statistics System and independent variables are from several official sources. Latent profile analysis (LPA) is used to identify drug clusters by classifying counties into profiles based on mortality rates across six drug types in 2017–19 and change from 2000 to 02. A multivariate general linear model is used to explore unconditional mean differences by latent profile across a number of variables. LPA identified seven classes. These clusters vary by key covariates, with a cocaine and illicit opioid problem concentrating in relatively affluent urban areas, a methamphetamine problem in rural areas, a prescription drug problem concentrated in a few states, and a syndemic in places that were the origin of the opioid pill epidemic of preceding decades. There is no longer a single drug crisis in the U.S. Rather, the problem is diverse, spatially. A single national drug policy response is unlikely to be equally effective in all parts, but findings speak to responses that have promise in particular contexts. Publisher Abstract Provided
Downloads
Similar Publications
- Adapting a Dialectical Behavior Therapy Skills Group Within a Jail Setting: Implementation Challenges and Considerations
- Grooming Traffickers: Investigating the Techniques and Mechanisms for Seducing and Coercing New Traffickers
- High-throughput LC-PDA Method for Determination of Δ9-THC and Related Cannabinoids in Cannabis Sativa